Katalina Muñoz-Durango

Dr. Katalina Muñoz-Durango

Vidarium - Nutrition, Health and Wellness Research Center, Nutresa Group.
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Redox Biology
Verified
Journal Article
Open access
OGOscar Javier Lara Guzman
Oscar Javier Lara Guzman
Angel Gil-IzquierdoAngel Gil-Izquierdo
Angel Gil-Izquierdo
Sonia MedinaSonia Medina
Sonia Medina
EOEdison Osorio
Edison Osorio
RARafael Alvarez-Quintero
Rafael Alvarez-Quintero
KMKatalina Muñoz-Durango
Katalina Muñoz-Durango
Oxidized low-density lipoprotein (oxLDL) is a well-recognized proatherogenic particle that functions in atherosclerosis. In this study, we established conditions to generate human oxLDL, characterized according to the grade of lipid and protein oxidation, particle size and oxylipin content. The induction effect of the cellular proatherogenic response was assessed in foam cells by using an oxLDL-macrophage interaction model. Uptake of oxLDL, reactive oxygen species production and expression of oxLDL receptors (CD36, SR-A and LOX-1) were significantly increased in THP-1 macrophages. Analyses of 35 oxylipins revealed that isoprostanes (IsoP) and prostaglandins (PGs) derived from the oxidation of arachidonic, dihomo gamma-linolenic and eicosapentaenoic acids were strongly and significantly induced in macrophages stimulated with oxLDL. Importantly, the main metabolites responsible for the THP1-macrophage response to oxLDL exposure were the oxidative stress markers 5-epi-5-F2t-IsoP, 15-E1t-IsoP, 8-F3t-IsoP and 15-keto-15-F2t-IsoP as well as inflammatory markers PGDM, 17-trans-PGF3α, and 11β-PGF2α, all of which are reported here, for the first time, to function in the interaction of oxLDL with THP-1 macrophages. By contrast, a salvage pathway mediated by anti-inflammatory PGs (PGE1 and 17-trans-PGF3α) was also identified, suggesting a response to oxLDL-induced injury. In conclusion, when THP-1 macrophages were treated with oxLDL, a specific induction of biomarkers related to oxidative stress and inflammation was triggered. This work contributes to our understanding of initial atherogenic events mediated by oxLDL-macrophage interactions and helps to generate new approaches for their modulation.

1 March 2016 in The Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
GAGloria M Agudelo-Ochoa
Gloria M Agudelo-Ochoa
IPIsabel C Pulgarín-Zapata
Isabel C Pulgarín-Zapata
CVClaudia Velásquez
Claudia Velásquez
MDMauricio Duque-Ramírez
Mauricio Duque-Ramírez
MNMauricio Naranjo-Cano
Mauricio Naranjo-Cano
KMKatalina Muñoz-Durango
Katalina Muñoz-Durango
Background: Coffee, a source of antioxidants, has controversial effects on cardiovascular health.Objective: We evaluated the bioavailability of chloro

27 February 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
ECErika Caro-Gómez
Erika Caro-Gómez
JRJelver Alexander Sierra Restrepo
Jelver Alexander Sierra Restrepo
Juan EscobarJuan Escobar
Juan Escobar
RARafael Alvarez-Quintero
Rafael Alvarez-Quintero
MNMauricio Naranjo
Mauricio Naranjo
JRJosé R. Ramírez-Pineda
José R. Ramírez-Pineda
Chlorogenic acids (CGA) are the most abundant phenolic compounds in green coffee beans and in the human diet and have been suggested to mitigate several cardiometabolic risk factors. Here, we aimed to evaluate the effect of a water-based standardized green coffee extract (GCE) on cardiometabolic parameters in ApoE-/- mice and to explore the potential underlying mechanisms. Mice were fed an atherogenic diet without (vehicle) or with GCE by gavage (equivalent to 220 mg/kg of CGA) for 14 weeks. We assessed several metabolic, pathological, and inflammatory parameters and inferred gut microbiota composition, diversity, and functional potential. Although GCE did not reduce atherosclerotic lesion progression or plasma lipid levels, it induced important favorable changes. Specifically, improved metabolic parameters, including fasting glucose, insulin resistance, serum leptin, urinary catecholamines, and liver triglycerides, were observed. These changes were accompanied by reduced weight gain, decreased adiposity, lower inflammatory infiltrate in adipose tissue, and protection against liver damage. Interestingly, GCE also modulated hepatic IL-6 and total serum IgM and induced shifts in gut microbiota. Altogether, our results reveal the cooccurrence of these beneficial cardiometabolic effects in response to GCE in the same experimental model and suggest potential mediators and pathways involved.

1 November 2016 in Food Research International
Verified
Journal Article
Closed access
OGOscar Javier Lara Guzman
Oscar Javier Lara Guzman
RARafael Alvarez-Quintero
Rafael Alvarez-Quintero
EOEdison Osorio
Edison Osorio
MNMauricio Naranjo-Cano
Mauricio Naranjo-Cano
KMKatalina Muñoz-Durango
Katalina Muñoz-Durango

1 November 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
OLOscar J. Lara-Guzmán
Oscar J. Lara-Guzmán
RÁRafael Álvarez
Rafael Álvarez
KMKatalina Muñoz-Durango
Katalina Muñoz-Durango
Lipid metabolism dysregulation is associated with cardiovascular disease (CVD) risk. Specific oxidized lipids are recognized CVD biomarkers involved in all stages of atherosclerosis, including foam cell formation. Moderate coffee intake is positively associated with cardiovascular health. A randomized, controlled (n = 25) clinical trial was conducted in healthy subjects to assess the changes in lipid species relevant to CVD (main inclusion criteria: coffee drinkers, nonsmokers, with no history and/or diagnosis of chronic disease and not consuming any medications). Volunteers consumed a coffee beverage (400 mL/day) containing either 787 mg (coffee A; n = 24) or 407 mg (coffee B; n = 25) of chlorogenic acids for eight weeks. We measured the total plasma levels of 46 lipids, including fatty acids, sterols, and oxysterols, at baseline and after eight weeks and assessed the effects of chlorogenic and phenolic acids, the major coffee antioxidants, in an in vitro foam cell model via targeted lipidomics. At baseline (n = 74), all participants presented oxysterols and free fatty acids (FFAs) (CVD risk markers), which are closely correlated to among them, but not with the classical clinical variables (lipid profile, waist circumference, and BMI). After eight weeks, the control group lipidome showed an increase in oxysterols (+7 ± 10%) and was strongly correlated with FFAs (e.g., arachidonic acid) and cholesteryl ester reduction (-13 ± 7%). Notably, the coffee group subjects (n = 49) had increased cholesteryl esters (+9 ± 11%), while oxysterols (-71 ± 30%) and FFAs (-29 ± 26%) decreased. No differences were found between the consumption of coffees A and B. Additionally, coffee antioxidants decreased oxysterols and regulated arachidonic acid in foam cells. Our results suggest that coffee consumption modulates the generation of oxidized and inflammatory lipids in healthy subjects, which are fundamental during CVD development. The clinical trial was registered on the International Clinical Trials Registry Platform, WHO primary registry (RPCEC00000168).

1 November 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
OGOscar Javier Lara Guzman
Oscar Javier Lara Guzman
Sonia MedinaSonia Medina
Sonia Medina
RÁRafael Álvarez
Rafael Álvarez
COCamille Oger
Camille Oger
TDThierry Durand
Thierry Durand
KMKatalina Muñoz-Durango
Katalina Muñoz-Durango